Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China
· Delayed Price · Currency is CNY 28.49
-1.35 (-4.52%)
Apr 29, 2026, 3:04 PM CST
SHE:002082 Revenue
In the year 2025, Wanbangde Pharmaceutical Holding Group had annual revenue of 1.14B CNY, down -20.69%. Wanbangde Pharmaceutical Holding Group had revenue of 127.01M in the quarter ending December 31, 2025, a decrease of -65.57%.
Revenue
1.14B
Revenue Growth
-20.69%
P/S Ratio
15.95
Revenue / Employee
763.65K
Employees
1,499
Market Cap
18.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.14B | -298.65M | -20.69% |
| Dec 31, 2024 | 1.44B | -98.57M | -6.39% |
| Dec 31, 2023 | 1.54B | -244.49M | -13.69% |
| Jan 1, 2023 | 1.79B | -144.17M | -7.47% |
| Jan 1, 2022 | 1.93B | -11.77B | -85.91% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Double-Crane Pharmaceutical | 10.73B |
| Fujian Cosunter Pharmaceutical | 430.98M |
| Walvax Biotechnology | 2.40B |
| ApicHope Pharmaceutical Group | 940.78M |
| Tonghua Dongbao Pharmaceutical | 2.95B |
| Joincare Pharmaceutical Group Industry | 14.85B |
| Shandong Buchang Pharmaceuticals | 10.96B |
| Hybio Pharmaceutical | 898.10M |